comparemela.com

Latest Breaking News On - Patrik kehler - Page 1 : comparemela.com

Glycotope to present platform approach for development of anti-GlycoTarget antibodies at 2024 AACR Meeting

Tärkeimmät ajankohtaiset talousuutiset, pörssikurssit ja kattavat sijoittajapalvelut löydät Kauppalehdestä.

United statesSan diegoPatrik kehlerGlycotope gmbAmerican association for cancer researchGlycotope gmbhCancer researchChief scientific officerTuesday aprPoster sectionPoster board number

Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec s immune cell engager platform

Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune cell engager platform Berlin, Germany, 11 Decem.

Henner kollenbergChris gardnerGlycotope gmbhPatrik kehlerChris welshGlycotope gmbEvotec se frankfurt stock exchangeFrankfurt stock exchangeChief scientific officer

Glycotope Presents anti-GlycoTarget Antibodies at the 2023 Society for Immunotherapy of Cancer (SITC) Meeting

Glycotope Presents anti-GlycoTarget Antibodies at the 2023 Society for Immunotherapy of Cancer (SITC) MeetingBerlin, Germany, 03 November, 2023 – .

United statesSan diegoPatrik kehlerGlycotope gmbSociety for immunotherapy of cancerGlycotarget antibodiesGlycotope gmbhChief scientific officerSaturday novExhibition hall

LegoChem Biosciences Enters Worldwide Licensing Agreement with Glycotope for Antibody Drug Conjugate Development

LegoChem Biosciences Enters Worldwide Licensing Agreement with Glycotope for Antibody Drug Conjugate Development
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

South koreaSoult ukpyolsiLegochem biosciencesHenner kollenbergGlycotope gmbDae young jeongPatrik kehlerChris welshGlycotope gmbhChris gardnerConsilium strategic communicationsAntibody drug conjugate developmentLegochem biosciences incAntibody drug conjugateGermany octoberYong zu kim

Glycotope and Max Delbrück Center enter into research collaboration to explore combination of GlycoTargets and CAR technology

Glycotope and Max Delbrück Center enter into research collaboration to explore combination of GlycoTargets and CAR technology
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Glycotope gmbArmin rehmMax delbrGlycotope gmbhChris gardnerPatrik kehlerJana schlChris welshBerlin institute of healthCommunications departmentHelmholtz associationHead of the translational tumorimmunology labTranslational tumorimmunology labCancer labGerman centerHelmholtz association max delbr

vimarsana © 2020. All Rights Reserved.